| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.0096 |
0.9 |
| mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |